Express Scripts Holding Net Income 2006-2018 | ESRX

Express Scripts Holding annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Express Scripts Holding net income for the quarter ending September 30, 2018 was $1.072B, a 27.31% increase year-over-year.
  • Express Scripts Holding net income for the twelve months ending September 30, 2018 was $4.900B, a 35.18% increase year-over-year.
  • Express Scripts Holding annual net income for 2017 was $4.517B, a 32.69% increase from 2016.
  • Express Scripts Holding annual net income for 2016 was $3.404B, a 37.47% increase from 2015.
  • Express Scripts Holding annual net income for 2015 was $2.476B, a 23.35% increase from 2014.
Express Scripts Holding Annual Net Income
(Millions of US $)
2017 $4,517
2016 $3,404
2015 $2,476
2014 $2,008
2013 $1,845
2012 $1,313
2011 $1,276
2010 $1,181
2009 $828
2008 $776
2007 $568
2006 $474
2005 $400
Express Scripts Holding Quarterly Net Income
(Millions of US $)
Q3 2018 $1,072
Q2 2018 $877
Q1 2018 $623
Q4 2017 $2,328
Q3 2017 $842
Q2 2017 $802
Q1 2017 $546
Q4 2016 $1,435
Q3 2016 $723
Q2 2016 $721
Q1 2016 $526
Q4 2015 $774
Q3 2015 $662
Q2 2015 $600
Q1 2015 $441
Q4 2014 $582
Q3 2014 $582
Q2 2014 $515
Q1 2014 $328
Q4 2013 $502
Q3 2013 $427
Q2 2013 $543
Q1 2013 $373
Q4 2012 $504
Q3 2012 $391
Q2 2012 $150
Q1 2012 $268
Q4 2011 $290
Q3 2011 $325
Q2 2011 $334
Q1 2011 $327
Q4 2010 $330
Q3 2010 $302
Q2 2010 $290
Q1 2010 $260
Q4 2009 $223
Q3 2009 $198
Q2 2009 $192
Q1 2009 $214
Q4 2008 $207
Q3 2008 $202
Q2 2008 $190
Q1 2008 $177
Q4 2007 $139
Q3 2007 $143
Q2 2007 $153
Q1 2007 $134
Q4 2006 $147
Q3 2006 $115
Q2 2006 $108
Q1 2006 $105
Q4 2005 $111
Q3 2005 $102
Q2 2005 $102
Q1 2005 $85
Sector Industry Market Cap Revenue
Medical Medical Services $55.055B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.186B 22.52
PRA Health Sciences (PRAH) United States $6.537B 26.68
Charles River Laboratories (CRL) United States $6.295B 22.07
HealthEquity (HQY) United States $5.293B 110.78
Premier (PINC) United States $5.276B 17.91
INC Research Holdings (SYNH) United States $5.161B 20.83
Teladoc (TDOC) United States $4.142B 0.00
NovoCure (NVCR) Jersey $2.933B 0.00
AMN Healthcare Services Inc (AMN) United States $2.890B 19.83
BioTelemetry (BEAT) United States $2.126B 37.55
Medpace Holdings (MEDP) United States $1.974B 24.42
Healthways (TVTY) United States $1.472B 18.10
Intrexon (XON) United States $1.393B 0.00
CareDx (CDNA) United States $1.165B 0.00
IKang Healthcare (KANG) China $1.161B 57.65
Natera (NTRA) United States $1.037B 0.00
China Cord Blood (CO) China $0.794B 21.07
Apollo Medical Holdings (AMEH) United States $0.742B 0.00
Surgery Partners (SGRY) United States $0.641B 0.00
Establishment Labs Holdings (ESTA) $0.536B 0.00
Civitas Solutions (CIVI) United States $0.525B 10.34
Interpace Diagnostics (IDXG) United States $0.034B 0.00
Cancer Genetics (CGIX) United States $0.014B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.004B 0.00